Insulin Delivery Devices Market - Growth opportunity due to Increasing Research, Development Activities and Increasing

1. Insulin Delivery Devices Market - Growth opportunity due to Increasing Research, Development Activities and Increasing Diabetes-Related Health Expenditure in Emerging Economies The report " Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021”, this market is expected to reach USD 17.85 Billion by 2021 from USD 11.54 Billion in 2016, growing at a CAGR of 9.1%. Browse 100 market data tables and 38 figures spread through 149 pages and in-depth TOC on "Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021" http://www.marketsandmarkets.com/Market-Reports/insulin-delivery-device-market-107632092.html Early buyers will receive 10% customization on reports. Industry Insights: Industry growth is driven by drivers in the market include favorable reimbursement scenario and government support in selected countries, technological advancements in insulin delivery devices, and growing diabetic population. Get The PDF Brochure For This Report: http://www.marketsandmarkets.com/pdfdownload.asp?id=107632092 Geographical Scenario: Based on geography, North America accounted for the largest share of the global insulin delivery devices market. In the coming years, the insulin delivery devices market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to the rising partnerships among the global and local players in Asia-Pacific countries. Moreover, high adoption of insulin pens and approvals for injectable insulin in Japan, increasing government initiatives in Singapore, and amendments in NDSS to broaden patient access to diabetes products in Australia are expected to support the growth of the Asia-Pacific insulin delivery devices market. Request Sample: http://www.marketsandmarkets.com/requestsample.asp?id=107632092 Industry Leaders: The prominent players in the Vaccine Adjuvants Market are Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.). Stakeholders of the Insulin Delivery Devices Market         Manufacturers of pen needles, insulin pens, pumps, syringes, and injectable drug delivery devices Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies Research institutes and academic centers Pharmaceutical and biopharmaceutical companies Biotechnology companies Authorities framing reimbursement policies for insulin delivery devices Business research and consulting service providers Venture capitalists

2. About MarketsandMarkets™: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441